• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Di

Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Di

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：initial1985
【摘 要】
：
Background Extramedullary relapse (EMR) of Acute Leukemia (AL) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a contributor to post-transplant mortality and remains poorly
【作 者】
：
Ling Ge Fan Ye Xinliang Mao Jia Chen Aining Sun Xiaming Zhu Huiying Qiu Zhengming Jin Miao Miao Chengcheng Fu Xiao Ma Feng Chen SHENGLI XUE CHENGGeng Ruan Depei Wu Xiaowen Tang 
【机 构】
：
The First Affiliated Hospital of Soochow University,Jiangsu Institute of Hematology
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Extramedullary relapse (EMR) of Acute Leukemia (AL) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a contributor to post-transplant mortality and remains poorly understood,especially the different characteristics of EMR between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients.
其他文献
Amino acid residue E543 in JAK2 C618R is a potential therapeutic target for myeloproliferative disor
Janus kinase 2 (JAK2) is an important mediator of cytokine receptor signaling and plays a key role in the hematopoietic and immune responses.The acquired JAK2 C618R somatic mutation is detected in a s
会议
The PHOENIX Study A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Ibrutinib Combined
Background Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease that can be classified by immunohistochemistry into 2 subgroups germinal center B-cell-like (GCB) or non-GCB (a subgroup inc
会议
Preliminary Prevalence Estimate of Multicentric Castleman's Disease in Asia-Pacific
Background Multicentric Castlemans Disease (MCD) is a very rare lymphoproliferative disorder of unknown etiology;dysregulated interleukin-6 production is a known pathogenic factor (El-Osta and Kurzroc
会议
The Analysis of Prognostic significance of Absolute Lymphocyte count and Lymphocyte-to-Monocyte Rati
Objective To evaluate the prognostic value of absolute lymphocyte count (ALC)and lymphocyte-to-monocyte ratio (LMR) in Diffuse large B-cell lymphoma(DLBCL) when they are diagnosised.
会议
Management situation and reactivation of hepatitis B virus in patients with chronic lymphocytic leuk
Purpose To our knowledge,the reported studies on the reactivation of Hepatitis B virus (HBV) in NHL were mostly on DLBCL;dates on the incidence and prognostication of HBV infection and HBV reactivatio
会议
Interim results from a phase II study of non-anthracycline combination of oxaliplatin-gemcitabine pl
Introduction Anthracycline-containing regimens (CHOP and CHOP-like regimens) are still the cornerstone of elderly patients with diffuse large B-cell lymphoma (DLBCL),although the therapeutic response
会议
The Prognostic Value of Immunohistochemical Algorithms in Patients with Diffuse Large B Cell Lymphom
Purpose Diffuse large B cell lymphoma (DLBCL) is the most common Non-Hodgkin Lymphomas.The clinical and pathological heterogeneity of this entity makes prognostic assessment difficult.Gene expression
会议
Investigation of the key T Cells and Cytokines of aGVHD after Allogeneic Hematopoietic Stem Cell Tra
Methods 64 patients were included in the study,from May 2013 to January 2014.Blood samples of these patients were monitoring every week.Treg,Th1 and Th17 cells number were detected by flow cytometry.S
会议
Activated monocyte-phagocytes probably initiate the onset of pre-engraftment syndrome (PES) followin
Objective To explore the main effective cells and the pathogenesis of pre-engraftment syndrome (PES) in patients with hematological malignancies after umbilical cord blood transplantation Methods We s
会议
The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the co
esenchymal stromal cells (MSCs) have been developed for the prevention and treatment of graft-versus-host disease (GVHD).Non-cultured natural MSCs are considered ideal,as they better maintain their bi
会议